Pfizer, GSK completes transaction to form new consumer healthcare JV Medical Dialogues Bureau3 Aug 2019 9:40 AM ISTThe Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and...
GSK expects shingles drug sales to exceed $1.3 billion Garima2 May 2019 9:00 AM ISTFTSE-100 member GSK, whose shares were up 0.3 per cent to 1,580 pence at 1156 GMT, also said it had decided to stop the clinical development of its...
Glaxo Smith Kline Chairman Philip Hampton to step down Farhat Nasim22 Jan 2019 9:00 AM IST"Following the announcement of our deal with Pfizer and the intended separation of the new consumer business, I believe this is the right moment to...
New GSK shingles vaccine off to strong start in key US market Ruby Khatun Khatun12 April 2018 9:45 AM ISTLONDON: GlaxoSmithKline's (GSK) new shingles vaccine - a priority product as the company strives to improve its drugs line-up - has won more than 90...
Reckitt Benckiser pulls out of Pfizer consumer health auction Ruby Khatun Khatun23 March 2018 10:00 AM ISTBritish consumer goods maker Reckitt Benckiser Group said it had ended discussions with Pfizer Inc over buying its consumer healthcare business, a day...
GSK appoints scientist Barron as new Research and Development head Ruby Khatun Khatun10 Nov 2017 9:47 AM ISTLONDON: GlaxoSmithKline (GSK) has poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head as new Chief...
GSK bets on pioneering cancer therapy with Adaptimmune deal Ruby Khatun Khatun9 Sept 2017 9:32 AM ISTLONDON: GlaxoSmithKline (GSK) said it has licensed the rights to Adaptimmune's pioneering T-cell therapy program to boost its pipeline in oncology,...
